Director/PDMR Shareholding

RNS Number : 2892C
GlaxoSmithKline PLC
12 April 2013
 



 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

 

I give below details of changes in the interests of Directors or Persons Discharging Managerial Responsibility in the Ordinary Shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary Shares at a price of 1560.192 pence per Ordinary Share on 11 April 2013 as a result of the reinvestment of dividends paid on Ordinary Shares held in the GlaxoSmithKline ShareReward Plan (the Plan).

 

Sir Andrew Witty

Acquisition of 31 Ordinary Shares

 

Mr S Dingemans

Acquisition of 6 Ordinary Shares

 

Mr S M Bicknell

Acquisition of 46 Ordinary Shares

 

Mr R G Connor

Acquisition of 39 Ordinary Shares

 

Mr S A Hussain

Acquisition of 8 Ordinary Shares

 

Mr D S Redfern

Acquisition of 46 Ordinary Shares

 

Ms C Thomas

Acquisition of 46 Ordinary Shares

 

Mr P C Thomson

Acquisition of 20 Ordinary Shares

 

Dr P J T Vallance

Acquisition of 24 Ordinary Shares

Ms E Walmsley

Acquisition of 2 Ordinary Shares

Mrs V A Whyte

Acquisition of 30 Ordinary Shares

 

The Company and the above-mentioned persons were advised of this information on

12 April 2013.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

12 April 2013


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQLLFFXZFFBBB

Companies

GSK (GSK)
UK 100